Dr. Julie-Ann Penton is the Director of Pharmaceutical Development at Therakind Limited. Julie-Ann is currently focused on the development of dry powder intranasal products and has worked on Therakinds DriDose® portfolio since inception. Julie-Ann’s career started in respiratory drug development with Sanofi Aventis and she has held a number of senior pharmaceutical development and consultancy positions with a focus on drug-device combinations. Julie-Ann has a broad experience of pharmaceutical development having played a pivotal role in bringing a number of products to market. Julie-Ann graduated with a degree in Pharmacy from Aston University and a PhD in pharmaceutical drug delivery from The University of Manchester.
